As Vaccines Near the Possible-Approval Line, New Challenges Await

Eight months after it began developing its Covid-19 vaccine, Pfizer formally filed for emergency use authorization from the US Food and Drug Administration on Friday. https://www.npr.org/2020/11/20/937026003/pfizer-asks-fda-to-approve-its-covid-19-vaccine-for-emergency-use

“Filing for Emergency Use Authorization in the U.S. is a critical step in making our vaccine candidate available to the global population as quickly as possible,” BioNTech CEO Ugur Sahin, MD, said in a  joint statement…

Read Entire Article Here…

Leave a Reply

Your email address will not be published. Required fields are marked *